Chronic migraine with or without aura was significantly associated with an increased risk for PPD, particularly in women with psychiatric and obstetric comorbidities.

Ubrogepant, approved for acute treatment of migraine, may also reduce nonheadache symptoms that occur in the hours preceding ...

The most common migraine classifications are: migraine without aura and migraine with aura. Aura symptoms include visual disturbances, affecting their vision or other senses. This affects around ...

The drug ubrogepant doesn't just ease the headache of a migraine, but also relieves symptoms like neck stiffness and fatigue ...

A drug to treat migraine, ubrogepant, is also found to reduce common non-headache symptoms that occur in the hours preceding ...

Women with both migraines and early menopause symptoms face dramatically higher heart risk. Learn the warning signs and ...

And once she became a mom, her migraine attacks made it tough to spend time with her kids. “It would take me out of the game, ...

Atzumi combines a proprietary advanced powder and device technology to simplify nasal delivery of dihydroergotamine for acute treatment of migraine.

Often brushed off as just bad headaches, migraines are neurological events with various symptoms, types, and triggers which demand proper diagnosis and personalised treatment.

If you're a migraine sufferer familiar with that early "aura" and other symptoms that pop up before the main pain hits, the ...

DHE is a migraine-specific acute medication first approved in 1946. The FDA's approval of the nasal powder formulation, ...